1.
Eder P, Łykowska-Szuber L, Krela-Kaźmierczak I, et al. Safety profile of anti-tumor necrosis factor therapy in inflammatory bowel disease – a single center experience. JMS. 2015;84(3):146-151. doi:10.20883/medical.e11